ACTONP53.: Pharmacological regulation of p53 proteins: On the way to new anticancer therapies (Q2878469): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 40.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 18,978.4 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
40.0 percent
| |||||||||||
| Property / co-financing rate: 40.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 17:38, 4 November 2022
Project Q2878469 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ACTONP53.: Pharmacological regulation of p53 proteins: On the way to new anticancer therapies |
Project Q2878469 in Portugal |
Statements
18,978.4 Euro
0 references
47,446.0 Euro
0 references
40.0 percent
0 references
1 April 2016
0 references
1 April 2019
0 references
ICETA - INSTITUTO DE CIÊNCIAS, TECNOLOGIAS E AGROAMBIENTE DA UNIVERSIDADE DO PORTO
0 references
Q2993305 (Deleted Item)
0 references
Identifiers
LISBOA-01-0145-FEDER-016581
0 references